Industry Roundup: Colgate, GNC, Sanofi, Pfizer Earnings
This article was originally published in The Tan Sheet
Colgate flat in North America; Allegra strengthens Sanofi consumer; Nexium helps Pfizer consumer; GNC ad cutback a ‘self-inflicted wound’; and more news in brief.
You may also be interested in...
US medtech companies are worried EU notified bodies have too much freedom over setting their fees, accusing them of lacking transparency and being inconsistent with what they charge. They also allege that notified body practices mean some products will miss the four-year grace period.
For health-care providers and medtech manufacturers alike, the decade ahead will require a coming to terms with digital technologies and integrating new methods of payment. Quality of service delivery remains the market-entry criterion, but companies will have to adapt to evolving health-care models. The stakes are high. Will manufacturers be able to capitalize on the changes in a market that is more competitive and unpredictable than ever?